{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:15:01Z","timestamp":1785798901237,"version":"3.56.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172639"],"award-info":[{"award-number":["82172639"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011407","name":"Key Laboratory of Jiangsu Province for Chemical Pollution Control and Resources Reuse","doi-asserted-by":"publisher","award":["ZDXKB2016014"],"award-info":[{"award-number":["ZDXKB2016014"]}],"id":[{"id":"10.13039\/501100011407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017287","name":"Special Funds for the Basic Research and Development Program in the Central Non-profit Research Institutesof China","doi-asserted-by":"publisher","award":["2023-LCYJ-MS-15"],"award-info":[{"award-number":["2023-LCYJ-MS-15"]}],"id":[{"id":"10.13039\/501100017287","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00259-025-07148-8","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T05:09:00Z","timestamp":1739768940000},"page":"2804-2813","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pathological and radiological features of false-positive lesions on [68Ga]Ga-PSMA-11 PET\/CT in primary staging of prostate cancer: a radio-pathology matching analysis"],"prefix":"10.1007","volume":"52","author":[{"given":"Renjie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyue","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3554-5145","authenticated-orcid":false,"given":"Xuefeng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"key":"7148_CR1","doi-asserted-by":"publisher","first-page":"175883592312213","DOI":"10.1177\/17588359231221342","volume":"16","author":"I Farkas","year":"2024","unstructured":"Farkas I, Sipka G, Bakos A, Mar\u00e1z A, Bajory Z, Mik\u00f3 Z, et al. Diagnostic value of [(99m)tc]Tc-PSMA-I&S-SPECT\/CT for the primary staging and restaging of prostate cancer. Ther Adv Med Oncol. 2024;16:17588359231221342. https:\/\/doi.org\/10.1177\/17588359231221342.","journal-title":"Ther Adv Med Oncol"},{"key":"7148_CR2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2214\/ajr.20.23912","volume":"216","author":"S Satapathy","year":"2021","unstructured":"Satapathy S, Singh H, Kumar R, Mittal BR. Diagnostic accuracy of (68)Ga-PSMA PET\/CT for initial detection in patients with suspected prostate Cancer: a systematic review and Meta-analysis. AJR Am J Roentgenol. 2021;216:599\u2013607. https:\/\/doi.org\/10.2214\/ajr.20.23912.","journal-title":"AJR Am J Roentgenol"},{"key":"7148_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00259-023-06392-0","volume":"51","author":"F Gossili","year":"2023","unstructured":"Gossili F, Mogensen AW, Konnerup TC, Bouchelouche K, Alberts I, Afshar-Oromieh A, et al. The diagnostic accuracy of radiolabeled PSMA-ligand PET for tumour staging in newly diagnosed prostate cancer patients compared to histopathology: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2023;51:281\u201394. https:\/\/doi.org\/10.1007\/s00259-023-06392-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7148_CR4","doi-asserted-by":"publisher","first-page":"215883","DOI":"10.1016\/j.canlet.2022.215883","volume":"548","author":"J Jiao","year":"2022","unstructured":"Jiao J, Zhang J, Li Z, Wen W, Cui C, Zhang Q, et al. Prostate specific membrane antigen positron emission tomography in primary prostate cancer diagnosis: first-line imaging is afoot. Cancer Lett. 2022;548:215883. https:\/\/doi.org\/10.1016\/j.canlet.2022.215883.","journal-title":"Cancer Lett"},{"key":"7148_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1053\/j.semnuclmed.2023.07.001","volume":"54","author":"MR Jochumsen","year":"2024","unstructured":"Jochumsen MR, Bouchelouche K. PSMA PET\/CT for primary staging of prostate Cancer - an updated overview. Semin Nucl Med. 2024;54:39\u201345. https:\/\/doi.org\/10.1053\/j.semnuclmed.2023.07.001.","journal-title":"Semin Nucl Med"},{"key":"7148_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.03.027","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2024. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.027.","journal-title":"Eur Urol"},{"key":"7148_CR7","doi-asserted-by":"publisher","unstructured":"Mojsak M, Szumowski P, Amelian A, Hladunski M, Kubas B, My\u015bliwiec J, et al. Application of 18F-PSMA-1007 PET\/MR Imaging in early biochemical recurrence of prostate Cancer: results of a prospective study of 60 patients with very low PSA levels\u2009\u2264\u20090.5 ng\/mL. Cancers (Basel). 2023;15. https:\/\/doi.org\/10.3390\/cancers15164185.","DOI":"10.3390\/cancers15164185"},{"key":"7148_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","volume":"77","author":"M Perera","year":"2020","unstructured":"Perera M, Papa N, Roberts M, Williams M, Udovicich C, Vela I, et al. Gallium-68 prostate-specific membrane Antigen Positron Emission Tomography in Advanced prostate Cancer-updated diagnostic utility, sensitivity, specificity, and distribution of prostate-specific membrane Antigen-avid lesions: a systematic review and Meta-analysis. Eur Urol. 2020;77:403\u201317. https:\/\/doi.org\/10.1016\/j.eururo.2019.01.049.","journal-title":"Eur Urol"},{"key":"7148_CR9","doi-asserted-by":"publisher","first-page":"668","DOI":"10.2967\/jnumed.115.154153","volume":"56","author":"M Eiber","year":"2015","unstructured":"Eiber M, Maurer T, Souvatzoglou M, Beer AJ, Ruffani A, Haller B, et al. Evaluation of Hybrid \u2076\u2078Ga-PSMA ligand PET\/CT in 248 patients with biochemical recurrence after radical prostatectomy. J Nucl Med. 2015;56:668\u201374. https:\/\/doi.org\/10.2967\/jnumed.115.154153.","journal-title":"J Nucl Med"},{"key":"7148_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41391-019-0156-z","volume":"23","author":"S Kimura","year":"2020","unstructured":"Kimura S, Abufaraj M, Janisch F, Iwata T, Parizi MK, Foerster B, et al. Performance of [(68)Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2020;23:1\u201310. https:\/\/doi.org\/10.1038\/s41391-019-0156-z.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"7148_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.04.010","author":"D Tilki","year":"2024","unstructured":"Tilki D, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer. Part II-2024 update: treatment of relapsing and metastatic prostate Cancer. Eur Urol. 2024. https:\/\/doi.org\/10.1016\/j.eururo.2024.04.010.","journal-title":"Eur Urol"},{"key":"7148_CR12","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3390\/diagnostics11101829","volume":"11","author":"F Midiri","year":"2021","unstructured":"Midiri F, Vernuccio F, Purpura P, Alongi P, Bartolotta TV. Multiparametric MRI and Radiomics in prostate Cancer: a review of the current literature. Diagnostics. 2021;11:1829.","journal-title":"Diagnostics"},{"key":"7148_CR13","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00261-016-0975-5","volume":"42","author":"DT Oberlin","year":"2017","unstructured":"Oberlin DT, Casalino DD, Miller FH, Meeks JJ. Dramatic increase in the utilization of multiparametric magnetic resonance imaging for detection and management of prostate cancer. Abdom Radiol (NY). 2017;42:1255\u20138. https:\/\/doi.org\/10.1007\/s00261-016-0975-5.","journal-title":"Abdom Radiol (NY)"},{"key":"7148_CR14","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.juro.2016.02.3000","volume":"196","author":"H Rhee","year":"2016","unstructured":"Rhee H, Thomas P, Shepherd B, Gustafson S, Vela I, Russell PJ, et al. Prostate specific membrane Antigen Positron Emission Tomography May improve the diagnostic accuracy of Multiparametric Magnetic Resonance Imaging in localized prostate Cancer. J Urol. 2016;196:1261\u20137. https:\/\/doi.org\/10.1016\/j.juro.2016.02.3000.","journal-title":"J Urol"},{"key":"7148_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00259-018-4160-7","volume":"46","author":"P Donato","year":"2019","unstructured":"Donato P, Roberts MJ, Morton A, Kyle S, Coughlin G, Esler R, et al. Improved specificity with (68) Ga PSMA PET\/CT to detect clinically significant lesions invisible on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology. Eur J Nucl Med Mol Imaging. 2019;46:20\u201330. https:\/\/doi.org\/10.1007\/s00259-018-4160-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7148_CR16","doi-asserted-by":"crossref","unstructured":"Esther M, Liza L, Peter C. The Impact of PSMA PET\/CT Imaging in Prostate Cancer Radiation Treatment. Seminars in nuclear medicine. 2022; 52:255\u2013\u200962.","DOI":"10.1053\/j.semnuclmed.2021.12.008"},{"key":"7148_CR17","doi-asserted-by":"crossref","unstructured":"Sabrina D, Kilian S, Katharina S, Matthias E, Tobias M, Markus S et al. Integration of (68)Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study. Radiation oncology (London, England). 2016; 11:73.","DOI":"10.1186\/s13014-016-0646-2"},{"key":"7148_CR18","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.radonc.2017.04.021","volume":"123","author":"C Zamboglou","year":"2017","unstructured":"Zamboglou C, Sachpazidis I, Koubar K, Drendel V, Wiehle R, Kirste S, et al. Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using 68Ga-HBED-CC PSMA-PET\/CT: a planning study based on histopathology reference. Radiother Oncol. 2017;123:472\u20137.","journal-title":"Radiother Oncol"},{"key":"7148_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-023-10436-2","author":"J Ma","year":"2023","unstructured":"Ma J, Yang Q, Ye X, Xu W, Chang Y, Chen R, et al. Head-to-head comparison of prostate-specific membrane antigen PET and multiparametric MRI in the diagnosis of pretreatment patients with prostate cancer: a meta-analysis. Eur Radiol. 2023. https:\/\/doi.org\/10.1007\/s00330-023-10436-2.","journal-title":"Eur Radiol"},{"key":"7148_CR20","doi-asserted-by":"publisher","first-page":"944","DOI":"10.2967\/jnumed.118.221010","volume":"60","author":"M Chen","year":"2019","unstructured":"Chen M, Zhang Q, Zhang C, Zhao X, Marra G, Gao J, et al. Combination of (68)Ga-PSMA PET\/CT and multiparametric MRI improves the detection of clinically significant prostate Cancer: a lesion-by-lesion analysis. J Nucl Med. 2019;60:944\u20139. https:\/\/doi.org\/10.2967\/jnumed.118.221010.","journal-title":"J Nucl Med"},{"key":"7148_CR21","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2967\/jnumed.123.266742","volume":"65","author":"J Shi","year":"2024","unstructured":"Shi J, Li D, Chen M, Fu Y, Peng S, Zhang Q, et al. The value of (68)Ga-PSMA PET\/MRI for classifying patients with PI-RADS 3 lesions on multiparametric MRI: a prospective single-center study. J Nucl Med. 2024;65:555\u20139. https:\/\/doi.org\/10.2967\/jnumed.123.266742.","journal-title":"J Nucl Med"},{"key":"7148_CR22","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/ju.0000000000003680","volume":"210","author":"W Tang","year":"2023","unstructured":"Tang W, Tang Y, Qi L, Zhang Y, Tang G, Gao X, et al. Benign Prostatic Hyperplasia-related false-positive of prostate-specific membrane Antigen-Positron Emission Tomography in the diagnosis of prostate Cancer: the Achilles\u2019 heel of Biopsy-Free Radical Prostatectomy? J Urol. 2023;210:845\u201355. https:\/\/doi.org\/10.1097\/ju.0000000000003680.","journal-title":"J Urol"},{"key":"7148_CR23","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.euf.2020.03.004","volume":"7","author":"E Lopci","year":"2021","unstructured":"Lopci E, Lughezzani G, Castello A, Saita A, Colombo P, Hurle R, et al. Prospective evaluation of (68)Ga-labeled prostate-specific membrane Antigen ligand Positron Emission Tomography\/Computed tomography in primary prostate Cancer diagnosis. Eur Urol Focus. 2021;7:764\u201371. https:\/\/doi.org\/10.1016\/j.euf.2020.03.004.","journal-title":"Eur Urol Focus"},{"key":"7148_CR24","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00259-018-3979-2","volume":"45","author":"DA Pizzuto","year":"2018","unstructured":"Pizzuto DA, M\u00fcller J, M\u00fchlematter U, Rupp NJ, T\u00f6pfer A, Mortezavi A, et al. The central zone has increased (68)Ga-PSMA-11 uptake: Mickey Mouse ears can be hot on (68)Ga-PSMA-11 PET. Eur J Nucl Med Mol Imaging. 2018;45:1335\u201343. https:\/\/doi.org\/10.1007\/s00259-018-3979-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7148_CR25","doi-asserted-by":"publisher","first-page":"12247","DOI":"10.18632\/oncotarget.14691","volume":"8","author":"S Zang","year":"2017","unstructured":"Zang S, Shao G, Cui C, Li TN, Huang Y, Yao X, et al. 68Ga-PSMA-11 PET\/CT for prostate cancer staging and risk stratification in Chinese patients. Oncotarget. 2017;8:12247\u201358. https:\/\/doi.org\/10.18632\/oncotarget.14691.","journal-title":"Oncotarget"},{"key":"7148_CR26","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.2967\/jnumed.121.263448","volume":"63","author":"L Emmett","year":"2022","unstructured":"Emmett L, Papa N, Buteau J, Ho B, Liu V, Roberts M, et al. The PRIMARY score: using Intraprostatic (68)Ga-PSMA PET\/CT patterns to optimize prostate Cancer diagnosis. J Nucl Med. 2022;63:1644\u201350. https:\/\/doi.org\/10.2967\/jnumed.121.263448.","journal-title":"J Nucl Med"},{"key":"7148_CR27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2967\/jnumed.123.266164","volume":"65","author":"L Emmett","year":"2024","unstructured":"Emmett L, Papa N, Counter W, Calais J, Barbato F, Burger I, et al. Reproducibility and accuracy of the PRIMARY score on PSMA PET and of PI-RADS on multiparametric MRI for prostate Cancer diagnosis within a real-world database. J Nucl Med. 2024;65:94\u20139. https:\/\/doi.org\/10.2967\/jnumed.123.266164.","journal-title":"J Nucl Med"},{"key":"7148_CR28","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s00259-019-04320-9","volume":"46","author":"J Gao","year":"2019","unstructured":"Gao J, Zhang C, Zhang Q, Fu Y, Zhao X, Chen M, et al. Diagnostic performance of (68)Ga-PSMA PET\/CT for identification of aggressive cribriform morphology in prostate cancer with whole-mount sections. Eur J Nucl Med Mol Imaging. 2019;46:1531\u201341. https:\/\/doi.org\/10.1007\/s00259-019-04320-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7148_CR29","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","volume":"0","author":"MS Hofman","year":"2020","unstructured":"Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multi-centre study. Lancet. 2020;0:1208\u201316.","journal-title":"Lancet"},{"key":"7148_CR30","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s00259-019-04620-0","volume":"47","author":"D Peter","year":"2020","unstructured":"Peter D, Andrew M, John Y, Sachinka R, E TP, Samuel K, et al. 68Ga-PSMA PET\/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: is 68Ga-PSMA PET\/CT guided biopsy the future? Eur J Nucl Med Mol Imaging. 2020;47:1843\u201351.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7148_CR31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41391-018-0048-7","volume":"21","author":"I Berger","year":"2018","unstructured":"Berger I, Annabattula C, Lewis J, Shetty DV, Kam J, Maclean F, et al. (68)Ga-PSMA PET\/CT vs. mpMRI for locoregional prostate cancer staging: correlation with final histopathology. Prostate Cancer Prostatic Dis. 2018;21:204\u201311. https:\/\/doi.org\/10.1038\/s41391-018-0048-7.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"7148_CR32","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.3760\/cma.j.cn112137-20200104-00021","volume":"100","author":"FY Yang","year":"2020","unstructured":"Yang FY, Li YJ, Han SJ, Chen D, Wu LY, Xiao ZJ, et al. [The preliminary clinical study on radical prostatectomy without preoperative prostate biopsy]. Zhonghua Yi Xue Za Zhi. 2020;100:2658\u201362. https:\/\/doi.org\/10.3760\/cma.j.cn112137-20200104-00021.","journal-title":"Zhonghua Yi Xue Za Zhi"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07148-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07148-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07148-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T05:22:57Z","timestamp":1749705777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07148-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["7148"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07148-8","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"28 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in line with the principles of the Declaration of Helsinki and approved by the Ethics Committee of the Drum Tower Hospital (2017-147-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Figs.\u00a02 and 4 and Supplementary Figs.\u00a01, 2.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}